Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility).
Thorax. 2020 Feb;75(2):176-179. doi: 10.1136/thoraxjnl-2019-213879. Epub 2020 Jan 8.
Thorax. 2020.
PMID: 31915308
Free PMC article.
Clinical Trial.
PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma.
Buckley HL, Collinson FJ, Ainsworth G, Poad H, Flanagan L, Katona E, Howard HC, Murden G, Banks RE, Brown J, Velikova G, Waddell T, Fife K, Nathan PD, Larkin J, Powles T, Brown SR, Vasudev NS.
Buckley HL, et al. Among authors: poad h.
BMC Cancer. 2019 Nov 14;19(1):1102. doi: 10.1186/s12885-019-6273-1.
BMC Cancer. 2019.
PMID: 31727024
Free PMC article.
Clinical Trial.
Item in Clipboard
Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study.
Oughton JB, Poad H, Twiddy M, Collinson M, Hiley V, Gordon K, Johnson M, Jain S, Noon AP, Chahal R, Simms M, Dooldeniya M, Koenig P, Goodwin L, Brown JM, Catto JWF; BRAVO study group.
Oughton JB, et al. Among authors: poad h.
BMJ Open. 2017 Aug 11;7(8):e017913. doi: 10.1136/bmjopen-2017-017913.
BMJ Open. 2017.
PMID: 28801444
Free PMC article.
Clinical Trial.
Item in Clipboard
Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study.
Catto JWF, Gordon K, Collinson M, Poad H, Twiddy M, Johnson M, Jain S, Chahal R, Simms M, Dooldeniya M, Bell R, Koenig P, Conroy S, Goodwin L, Noon AP, Croft J, Brown JM; BRAVO study group.
Catto JWF, et al. Among authors: poad h.
J Clin Oncol. 2021 Jan 20;39(3):202-214. doi: 10.1200/JCO.20.01665. Epub 2020 Dec 17.
J Clin Oncol. 2021.
PMID: 33332191
Free PMC article.
Clinical Trial.
Item in Clipboard
Individual participant data from digital sources informed and improved precision in the evaluation of predictive biomarkers in Bayesian network meta-analysis.
Umemneku-Chikere CM, Wheaton L, Poad H, Ray D, Andrade IC, Khan S, Tappenden P, Abrams KR, Owen RK, Bujkiewicz S.
Umemneku-Chikere CM, et al. Among authors: poad h.
J Clin Epidemiol. 2023 Dec;164:96-103. doi: 10.1016/j.jclinepi.2023.10.018. Epub 2023 Oct 31.
J Clin Epidemiol. 2023.
PMID: 37918640
Free article.
Item in Clipboard
The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status.
Poad H, Khan S, Wheaton L, Thomas A, Sweeting M, Bujkiewicz S.
Poad H, et al.
Cancers (Basel). 2022 Nov 1;14(21):5391. doi: 10.3390/cancers14215391.
Cancers (Basel). 2022.
PMID: 36358810
Free PMC article.
Item in Clipboard
Cite
Cite